• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纹状体致密部铁含量增加可识别早期帕金森病患者:3T 和 7T MRI 研究。

Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.

机构信息

Department of Neuroscience, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 3K7, Canada; Western Institute for Neuroscience, Western University, London, Ontario N6A 3K7, Canada.

Robarts Research Institute, Western University, London, Ontario N6A 3K7, Canada; Department of Medical Biophysics, Western University, London, Ontario N6A 3K7, Canada.

出版信息

Neuroimage Clin. 2024;41:103577. doi: 10.1016/j.nicl.2024.103577. Epub 2024 Feb 17.

DOI:10.1016/j.nicl.2024.103577
PMID:38377722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10944193/
Abstract

Degeneration in the substantia nigra (SN) pars compacta (SNc) underlies motor symptoms in Parkinson's disease (PD). Currently, there are no neuroimaging biomarkers that are sufficiently sensitive, specific, reproducible, and accessible for routine diagnosis or staging of PD. Although iron is essential for cellular processes, it also mediates neurodegeneration. MRI can localize and quantify brain iron using magnetic susceptibility, which could potentially provide biomarkers of PD. We measured iron in the SNc, SN pars reticulata (SNr), total SN, and ventral tegmental area (VTA), using quantitative susceptibility mapping (QSM) and R2* relaxometry, in PD patients and age-matched healthy controls (HCs). PD patients, diagnosed within five years of participation and HCs were scanned at 3T (22 PD and 23 HCs) and 7T (17 PD and 21 HCs) MRI. Midbrain nuclei were segmented using a probabilistic subcortical atlas. QSM and R2* values were measured in midbrain subregions. For each measure, groups were contrasted, with Age and Sex as covariates, and receiver operating characteristic (ROC) curve analyses were performed with repeated k-fold cross-validation to test the potential of our measures to classify PD patients and HCs. Statistical differences of area under the curves (AUCs) were compared using the Hanley-MacNeil method (QSM versus R2*; 3T versus 7T MRI). PD patients had higher QSM values in the SNc at both 3T (p = 0.001) and 7T (p = 0.01), but not in SNr, total SN, or VTA, at either field strength. No significant group differences were revealed using R2* in any midbrain region at 3T, though increased R2* values in SNc at 7T MRI were marginally significant in PDs compared to HCs (p = 0.052). ROC curve analyses showed that SNc iron measured with QSM, distinguished early PD patients from HCs at the single-subject level with good diagnostic accuracy, using 3T (mean AUC = 0.83, 95 % CI = 0.82-0.84) and 7T (mean AUC = 0.80, 95 % CI = 0.79-0.81) MRI. Mean AUCs reported here are from averages of tests in the hold-out fold of cross-validated samples. The Hanley-MacNeil method demonstrated that QSM outperforms R2* in discriminating PD patients from HCs at 3T, but not 7T. There were no significant differences between 3T and 7T in diagnostic accuracy of QSM values in SNc. This study highlights the importance of segmenting midbrain subregions, performed here using a standardized atlas, and demonstrates high accuracy of SNc iron measured with QSM at 3T MRI in identifying early PD patients. QSM measures of SNc show potential for inclusion in neuroimaging diagnostic biomarkers of early PD. An MRI diagnostic biomarker of PD would represent a significant clinical advance.

摘要

黑质致密部(SNc)的退变是帕金森病(PD)运动症状的基础。目前,尚无足够敏感、特异、可重复和易于常规诊断或分期的神经影像学生物标志物。尽管铁是细胞过程所必需的,但它也介导神经退行性变。MRI 可以使用磁化率定位和定量脑铁,这可能为 PD 提供生物标志物。我们使用定量磁化率图(QSM)和 R2弛豫率测量了 PD 患者和年龄匹配的健康对照者(HC)的 SNc、SN 网状部(SNr)、总 SN 和腹侧被盖区(VTA)中的铁。PD 患者在参加研究后的五年内被诊断出来,在 3T(22 名 PD 和 23 名 HC)和 7T(17 名 PD 和 21 名 HC)MRI 上进行扫描。使用概率性皮质下图谱对中脑核进行分割。在中脑亚区测量 QSM 和 R2值。对于每个测量值,都进行了组间对比,以年龄和性别为协变量,并使用重复 k 折交叉验证进行了接收器工作特征(ROC)曲线分析,以测试我们的测量值对 PD 患者和 HCs 进行分类的潜力。使用 Hanley-MacNeil 方法比较曲线下面积(AUC)的统计学差异(QSM 与 R2*;3T 与 7T MRI)。在这两种场强下,PD 患者的 SNc 的 QSM 值均较高(3T:p=0.001;7T:p=0.01),但在 SNr、总 SN 或 VTA 中没有这种差异。在 3T 时,在任何中脑区域使用 R2都没有显示出显著的组间差异,但在 PD 患者中,7T MRI 中 SNc 的 R2值稍高,与 HCs 相比具有边缘显著性(p=0.052)。ROC 曲线分析表明,使用 QSM 测量的 SNc 铁可以在单个受试者水平上以良好的诊断准确性区分早期 PD 患者和 HCs,使用 3T(平均 AUC=0.83,95%CI=0.82-0.84)和 7T(平均 AUC=0.80,95%CI=0.79-0.81)MRI。这里报告的平均 AUC 是从交叉验证样本的保留折叠测试平均值。Hanley-MacNeil 方法表明,在 3T 时,QSM 比 R2*在区分 PD 患者和 HCs 方面表现更好,但在 7T 时并非如此。在 SNc 的 QSM 值的诊断准确性方面,3T 和 7T 之间没有显著差异。本研究强调了对中脑亚区进行分割的重要性,这里使用标准化图谱进行了分割,并证明了在 3T MRI 上使用 QSM 测量 SNc 铁在识别早期 PD 患者方面具有很高的准确性。SNc 的 QSM 测量值有可能被纳入早期 PD 的神经影像学诊断生物标志物。PD 的 MRI 诊断生物标志物将是一个重大的临床进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/9ba7e2db4cf1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/bbde4a1a1921/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/51d26db8104b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/69ec67ba96c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/347e673175fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/eb9a0a79300a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/9ba7e2db4cf1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/bbde4a1a1921/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/51d26db8104b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/69ec67ba96c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/347e673175fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/eb9a0a79300a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae29/10944193/9ba7e2db4cf1/gr6.jpg

相似文献

1
Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.纹状体致密部铁含量增加可识别早期帕金森病患者:3T 和 7T MRI 研究。
Neuroimage Clin. 2024;41:103577. doi: 10.1016/j.nicl.2024.103577. Epub 2024 Feb 17.
2
Dorsal hyperintensity and iron deposition patterns in the substantia nigra of Parkinson's disease, idiopathic REM sleep behavior disorder, and Parkinson-plus syndromes at 7T MRI: a prospective diagnostic study.7T磁共振成像下帕金森病、特发性快速眼动睡眠行为障碍及帕金森叠加综合征患者黑质的背侧高信号和铁沉积模式:一项前瞻性诊断研究
Transl Neurodegener. 2025 Jul 4;14(1):35. doi: 10.1186/s40035-025-00495-4.
3
Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study.路易体病中的黑质铁沉积:一项磁共振成像与神经病理学研究
Mov Disord. 2025 Jun 23. doi: 10.1002/mds.30265.
4
Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms.帕金森病中红核与黑质致密部的神经病理学发现和体内影像学相关性比较。
Parkinsonism Relat Disord. 2024 Aug;125:107043. doi: 10.1016/j.parkreldis.2024.107043. Epub 2024 Jun 15.
5
Association between brain iron deposition and pure apathy in Parkinson's disease: a cross-sectional quantitative susceptibility mapping imaging study.帕金森病中脑铁沉积与单纯性淡漠之间的关联:一项横断面定量磁化率映射成像研究
Quant Imaging Med Surg. 2025 Sep 1;15(9):8292-8308. doi: 10.21037/qims-2024-2626. Epub 2025 Aug 12.
6
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.一种用于帕金森病灵敏且准确诊断的微创生物标志物。
medRxiv. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Early brain iron changes in Parkinson's disease and isolated rapid eye movement sleep behaviour disorder: a four-year longitudinal multimodal quantitative MRI study.帕金森病和孤立性快速眼动睡眠行为障碍的早期脑铁变化:一项为期四年的纵向多模态定量磁共振成像研究
Brain Commun. 2025 Jun 2;7(3):fcaf212. doi: 10.1093/braincomms/fcaf212. eCollection 2025.
9
Midbrain and pallidal iron changes identify patients with REM sleep behaviour disorder and Parkinson's disease.中脑和苍白球铁含量变化可识别快速眼动睡眠行为障碍和帕金森病患者。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):84. doi: 10.1038/s41531-025-00916-1.
10
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study.精神分裂症患者脑铁含量降低与纹状体多巴胺能亢进:一项定量磁化率成像MRI和PET研究
Am J Psychiatry. 2025 Sep 1;182(9):830-839. doi: 10.1176/appi.ajp.20240512.

引用本文的文献

1
Multiple Demographic, Lifestyle, and Biological Factors Associated With Brain Iron Deposition in the Basal Ganglia: A Comprehensive Analysis of 25,980 UK Biobank Participants.与基底节区脑铁沉积相关的多种人口统计学、生活方式和生物学因素:对25980名英国生物银行参与者的综合分析
Brain Behav. 2025 Sep;15(9):e70862. doi: 10.1002/brb3.70862.
2
Early brain iron changes in Parkinson's disease and isolated rapid eye movement sleep behaviour disorder: a four-year longitudinal multimodal quantitative MRI study.帕金森病和孤立性快速眼动睡眠行为障碍的早期脑铁变化:一项为期四年的纵向多模态定量磁共振成像研究
Brain Commun. 2025 Jun 2;7(3):fcaf212. doi: 10.1093/braincomms/fcaf212. eCollection 2025.
3

本文引用的文献

1
Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease.MRI 中黑质体-1 神经黑色素和铁的自动分割与定量:帕金森病的候选生物标志物。
J Magn Reson Imaging. 2024 Aug;60(2):534-547. doi: 10.1002/jmri.29073. Epub 2023 Nov 2.
2
Subregional analysis of striatum iron in Parkinson's disease and rapid eye movement sleep behaviour disorder.纹状体铁在帕金森病和快速眼动睡眠行为障碍中的亚区分析。
Neuroimage Clin. 2023;40:103519. doi: 10.1016/j.nicl.2023.103519. Epub 2023 Sep 28.
3
An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
The interplay of iron, oxidative stress, and α-synuclein in Parkinson's disease progression.
铁、氧化应激和α-突触核蛋白在帕金森病进展中的相互作用。
Mol Med. 2025 Apr 26;31(1):154. doi: 10.1186/s10020-025-01208-3.
4
Midbrain and pallidal iron changes identify patients with REM sleep behaviour disorder and Parkinson's disease.中脑和苍白球铁含量变化可识别快速眼动睡眠行为障碍和帕金森病患者。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):84. doi: 10.1038/s41531-025-00916-1.
5
Prospective motion correction for and susceptibility mapping using spherical navigators.使用球形导航器进行前瞻性运动校正和磁化率映射。
Magn Reson Med. 2025 Apr;93(4):1642-1656. doi: 10.1002/mrm.30385. Epub 2024 Dec 3.
6
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.神经影像学和液体生物标志物在靶向干预时代的帕金森病。
Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9.
7
Increased mean diffusivity of the caudal motor SNc identifies patients with REM sleep behaviour disorder and Parkinson's disease.尾侧运动性黑质致密部平均扩散率增加可识别快速眼动睡眠行为障碍和帕金森病患者。
NPJ Parkinsons Dis. 2024 Jun 29;10(1):128. doi: 10.1038/s41531-024-00731-0.
应用神经黑色素敏感 MRI 研究帕金森病患者黑质和蓝斑内神经黑色素的分布。
BMC Neurol. 2023 Aug 14;23(1):301. doi: 10.1186/s12883-023-03350-z.
4
Iron accumulation in the ventral tegmental area in Parkinson's disease.帕金森病中腹侧被盖区的铁蓄积
Front Aging Neurosci. 2023 Jun 28;15:1187684. doi: 10.3389/fnagi.2023.1187684. eCollection 2023.
5
Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson's disease.臂旁核伤害性处理的改变可能是帕金森病中枢性疼痛的基础。
NPJ Parkinsons Dis. 2023 May 26;9(1):78. doi: 10.1038/s41531-023-00516-x.
6
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's disease.脑干神经黑色素和铁的磁共振成像揭示了特发性和LRRK2帕金森病的精确特征。
NPJ Parkinsons Dis. 2023 Apr 15;9(1):62. doi: 10.1038/s41531-023-00503-2.
7
Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.帕金森病冻结步态患者黑质和蓝斑的神经黑色素磁共振成像
Front Aging Neurosci. 2023 Feb 2;15:1060935. doi: 10.3389/fnagi.2023.1060935. eCollection 2023.
8
Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?帕金森病的临床诊断准确性:我们处于何种水平?
Mov Disord. 2023 Apr;38(4):558-566. doi: 10.1002/mds.29317. Epub 2023 Jan 5.
9
Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars Compacta.易感性磁共振成像与黑质致密部神经胶质密度和 Tau 的相关性。
Mov Disord. 2023 Mar;38(3):464-473. doi: 10.1002/mds.29311. Epub 2023 Jan 4.
10
Neuromelanin-Sensitive Magnetic Resonance Imaging Changes in the Locus Coeruleus/Subcoeruleus Complex in Patients with Typical and Atypical Parkinsonism.典型和非典型帕金森病患者蓝斑/蓝斑下复合体中神经黑素敏感磁共振成像的变化
Mov Disord. 2023 Mar;38(3):479-484. doi: 10.1002/mds.29309. Epub 2023 Jan 2.